Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
608 Results for "
binding peptide
" in MedChemExpress (MCE) Product Catalog:
Products (608)
608 Results for "binding peptide" in MCE Product Catalog:
1
1 Cited Publications
Art. -Nr.: HY-P1741
CAS. Nr.: 137235-80-4
Target:
Forschungsgebiete:
Fibrinogen-Binding Peptide is a Fibrinogen-binding peptide. Fibrinogen-Binding Peptide inhibits platelet adhesion to vitronectin and fibrinogen. Fibrinogen-Binding Peptide inhibits platelet aggregation in ADP-stimulated platelet-rich plasma and in thrombin-stimulated washed platelets. Fibrinogen-Binding Peptide can be used for research on thrombosis .
1
1
1 Cited Publications
Art. -Nr.: HY-P1369
CAS. Nr.: 251634-22-7
Target:
Forschungsgebiete:
1
1 Cited Publications
Art. -Nr.: HY-P1083
CAS. Nr.: 251634-21-6
Target:
Forschungsgebiete:
1
1 Cited Publications
Art. -Nr.: HY-P1741A
Target:
Forschungsgebiete:
Fibrinogen-Binding Peptide TFA is a Fibrinogen-binding peptide. Fibrinogen-Binding Peptide TFA inhibits platelet adhesion to vitronectin and fibrinogen. Fibrinogen-Binding Peptide TFA inhibits platelet aggregation in ADP-stimulated platelet-rich plasma and in thrombin-stimulated washed platelets. Fibrinogen-Binding Peptide TFA can be used for research on thrombosis .
1
PSMA targeting peptide (PSMA-1) TFA is a PSMA-binding peptide that selectively binds to the PSMA receptor on prostate cancer cells and acts as a peptide-based siRNA delivery system by complexing and releasing siRNA. PSMA targeting peptide TFA can be used in research on prostate cancer .
1
1 Cited Publications
Art. -Nr.: HY-P10218A
Forschungsgebiete:
1
1
1
1 Cited Publications
Art. -Nr.: HY-P1663A
Target:
Forschungsgebiete:
ATWLPPR Peptide TFA, a heptapeptide, acts as a selective neuropilin-1 inhibitor, inhibits VEGF165 binding to NRP-1, used in the research of angiogenesis . ATWLPPR Peptide TFA has potential in reducing the early retinal damage caused by diabetes .
1
1 Cited Publications
Art. -Nr.: HY-P1663
CAS. Nr.: 272121-15-0
1
1
1 Cited Publications
Art. -Nr.: HY-P1376A
Target:
Forschungsgebiete:
1
1 Cited Publications
Art. -Nr.: HY-P10218
CAS. Nr.: 479482-23-0
Forschungsgebiete:
1
1 Cited Publications
Art. -Nr.: HY-P10495A
Target:
Forschungsgebiete:
1
1 Cited Publications
Art. -Nr.: HY-P10710A
Target:
Forschungsgebiete:
1
1 Cited Publications
Target:
Forschungsgebiete:
NRX-2663 is an enhancer of the interaction between β-catenin, and its cognate E3 ligase, SCF β-TrCP. NRX-2663 enhances the binding of β-catenin peptide for β-TrCP with an EC50 of 22.9 μM and a Kd of 54.8 nM .
1
1 Cited Publications
Art. -Nr.: HY-P1328
CAS. Nr.: 1362661-34-4
Target:
Forschungsgebiete:
1
1 Cited Publications
Art. -Nr.: HY-P7061A
Target:
Forschungsgebiete:
1
1 Cited Publications
Art. -Nr.: HY-148263
Reinheit: ≥98.0%
Target:
Forschungsgebiete:
Biotin-PEG2000-Thiol is an active compound. Biotin-PEG2000-Thiol is pegylated by binding to streptavidin or antibiotin with high affinity and specificity. Biotin-PEG2000-Thiol can modify biomolecules, proteins, peptides and other small molecule materials. Biotin-PEG2000-Thiol is widely used in the research of agent release and nano new materials .
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
